Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9457
+0.0107 (1.14%)
At close: Sep 8, 2025, 4:00 PM
0.9645
+0.0188 (1.99%)
After-hours: Sep 8, 2025, 4:08 PM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $42.69 million as of September 8, 2025. Its market cap has decreased by -74.58% in one year.
Market Cap
42.69M
Enterprise Value
67.85M
1-Year Change
-74.58%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $42.69M, a decrease of -56.15%. That is a compound annual growth rate of -8.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 41.53M | -11.77% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | 165.34M | 630.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |